NCT07252700 Preventing Diabetes: Impact of an EMR-Based Intervention for Enhanced Pre-Diabetes Management in Primary Care
| NCT ID | NCT07252700 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Lynette Goh |
| Condition | Pre Diabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 6,000 participants |
| Start Date | 2025-09-02 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 6,000 participants in total. It began in 2025-09-02 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to find out if adding electronic medical record (EMR) prompts helps prevent people with pre-diabetes from developing diabetes. It will also look at how these prompts affect doctor and patient behaviors. The main questions are: Does it improve follow-up care, such as blood tests, referrals, and medication? Does the EMR prompt reduce the number of patients who progress to diabetes within six months? Researchers will compare clinics that use EMR prompts with clinics that do not. Participants will: Receive usual care for pre-diabetes at their polyclinic In some clinics, doctors will see EMR prompts suggesting tests, referrals, and medication Complete surveys about their health and lifestyle at different time points
Eligibility Criteria
Inclusion Criteria for study population (EMR based analytic cohort): * All adults aged 21 to 59 years with prediabetes who attend any of the eight participating polyclinics during the study period will be included in the EMR-based analytic cohort. * Prediabetes is defined as impaired fasting glucose or impaired glucose tolerance according to standard clinical criteria, with either diagnosis documented in the EMR problem list or visit diagnosis. * Individuals with a prior diagnosis of diabetes will be excluded. Inclusion Criteria for patient surveys: * Adults aged 40-59 years * Diagnosed with prediabetes (impaired fasting glucose or impaired glucose tolerance) * Receiving routine follow-up care at NUP polyclinics * Able to provide written informed consent * Able to complete questionnaires in English Exclusion criteria for patient surveys: * Prior diagnosis of diabetes mellitus or gestational diabetes * Severe acute or chronic liver or kidney disease * Pregnancy * Cognitive impairment * Inability to communicate in English Inclusion Criteria for clinician surveys: * All clinicians that consult patients in National University Polyclinics * No exclusion criteria specified for clinicians
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07252700 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, up to 59 Years, studying Pre Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07252700 currently recruiting?
Yes, NCT07252700 is actively recruiting participants. Contact the research team at lynette_ml_goh@nuhs.edu.sg for enrollment information.
Where is the NCT07252700 trial being conducted?
This trial is being conducted at Singapore, Singapore.
Who is sponsoring the NCT07252700 clinical trial?
NCT07252700 is sponsored by Lynette Goh. The trial plans to enroll 6,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.